Zhende Historical Cash Flow
| 603301 Stock | 22.17 0.49 2.16% |
Analysis of Zhende Medical cash flow over time is an excellent tool to project Zhende Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 482.3 M or Total Cash From Operating Activities of 773.3 M as it is a great indicator of Zhende Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Zhende Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Zhende Medical is a good buy for the upcoming year.
Zhende |
About Zhende Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Zhende balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Zhende's non-liquid assets can be easily converted into cash.
Zhende Medical Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Zhende Medical to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Zhende Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Zhende Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Zhende Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Zhende Medical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, Zhende Medical's Net Borrowings is projected to increase significantly based on the last few years of reporting. The current year's Total Cash From Operating Activities is expected to grow to about 773.3 M, whereas Total Cashflows From Investing Activities is forecasted to decline to (523.9 M).
Zhende Medical cash flow statement Correlations
Click cells to compare fundamentals
Zhende Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Zhende Medical cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Borrowings | (61.1M) | 487.0M | 11.7M | 343.7M | 395.3M | 415.1M | |
| Total Cashflows From Investing Activities | (161.6M) | (319.1M) | (1.8B) | (554.4M) | (499.0M) | (523.9M) | |
| Other Cashflows From Financing Activities | (21.7M) | (465K) | (211.1M) | (98.8M) | (88.9M) | (84.4M) | |
| Capital Expenditures | 273.8M | 1.1B | 695.5M | 754.1M | 599.2M | 482.3M | |
| Total Cash From Operating Activities | 197.8M | 3.1B | 817.6M | 1.2B | 452.1M | 773.3M | |
| Change To Netincome | 27.0M | 52.4M | 643.4M | 169.5M | 194.9M | 150.2M | |
| Change To Liabilities | 57.0M | 121.1M | 976.5M | (443.2M) | (509.7M) | (484.2M) | |
| Change To Inventory | (47.4M) | (659.3M) | 279.1M | (228.7M) | (12.7M) | (13.3M) | |
| Change In Cash | 311.2M | 956.3M | (154.6M) | 705.6M | (1.0B) | (965.4M) | |
| Depreciation | 65.3M | 78.6M | 139.3M | 194.3M | 243.0M | 121.8M | |
| Dividends Paid | 58.3M | 78.3M | 543.7M | 164.3M | (423.7M) | (402.5M) | |
| Change To Account Receivables | (81.9M) | (150.9M) | (468.1M) | 49.7M | 44.7M | 47.0M | |
| Net Income | 156.9M | 2.5B | 595.9M | 681.1M | 198.4M | 188.5M | |
| Total Cash From Financing Activities | 349.3M | 428.2M | (277.7M) | (379.6M) | (341.6M) | (324.5M) | |
| End Period Cash Flow | 553.4M | 1.5B | 1.4B | 2.1B | 1.0B | 940.3M | |
| Free Cash Flow | (76.0M) | 2.0B | 122.2M | 491.9M | (147.1M) | (139.8M) | |
| Change In Working Capital | (77.1M) | (132.0M) | (114.4M) | 145.0M | (270.1M) | (256.6M) | |
| Begin Period Cash Flow | 242.2M | 553.4M | 1.5B | 1.4B | 2.1B | 2.2B | |
| Other Non Cash Items | 21.5M | 113.1M | 40.2M | 12.7M | 18.5M | 29.5M |
Currently Active Assets on Macroaxis
Other Information on Investing in Zhende Stock
The Cash Flow Statement is a financial statement that shows how changes in Zhende balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Zhende's non-liquid assets can be easily converted into cash.